Skip to main content
. 2022 Dec 28;18:100531. doi: 10.1016/j.mtbio.2022.100531

Fig. 4.

Fig. 4

(a) Confocal images of Hepa1-6 ​cells after incubated with DiO-modified PD1-CM or CHO-CM. Scale bar: 20 ​μm; (b) confocal images of Hepa1-6 ​cells and anti-PD-L1 antibody pre-treated Hepa1-6 ​cells after incubated with DiO-modified MnO2@PD1-CM, Scale bars: 20 ​μm; (c) DCFH-DA indicating the production of intracellular ROS in Hepa1-6 ​cells after treated with PD1-CM, MnO2 or MnO2@PD1-CM; cell viability of Hepa1-6 ​cells after treated with different concentrations of MnO2 (d) or MnO2@PD1-CM (e) for 24 ​h.